Ultomiris 300 MG/3 ML vial 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQV4C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,252
Award facts
- Contract value 100% obligated
- $28,251.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,251.74 to AmerisourceBergen Drug Corp for the supply of Ultomiris 300 mg/3 ml vials on January 28, 2026, with completion expected by February 19, 2026. This contract utilizes a firm fixed-price pricing structure with no set-aside designation, indicating full and open competition. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's performance will be executed from its corporate office location in Conshohocken, PA. Ultomiris is a complement inhibitor used in the treatment of rare blood disorders, reflecting the specialized pharmaceutical portfolio that AmerisourceBergen maintains across multiple therapeutic domains for military and veteran healthcare systems. This delivery order exemplifies the company's ongoing role in fulfilling federal medical supply requirements through the DLA's Troop Support Medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQV4C?
SPE2DR26FQV4C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FQV4C worth?
The government has obligated $28,252 on SPE2DR26FQV4C.
Is contract SPE2DR26FQV4C an order under another contract?
Yes. SPE2DR26FQV4C is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV4C competed?
The extent of competition for SPE2DR26FQV4C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award